About: Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.04 (+3.23%)
JBIO NASDAQ Jade Biosciences, Inc.
Jade Biosciences, Inc. share price
Atividade de preço de JBIO
Último preço
$ 15,040
Variação (24h)
0,47 USD (3,23%)
Volume
1.13M
Volume (média 4 sem.)
-
Abertura
$ 15,01
Variação do dia
$ 14,45 - $ 15,19
Fechamento anterior
$ 14,57
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
JBIO price performance
Atrasado
04 Nov, 9:00 pm GMT+0
JBIO details
quote.marketSignals